About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT01278693

Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients

The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.

Lead sponsor: Isfahan University of Medical Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Isfahan University of Medical Sciences

In patients under maintenance hemodialysis several factors reduce the body stored carnitine which in turn affected dyslipidemia, anemia, and general health in these patients. The investigators evaluated the effect of oral L-carnitine supplementation on lipid profiles, anemia, and quality of life in hemodialysis patients.

Age

18 - 75 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•being in the age range of 18-75 having the history of at least 12 weeks of hemodialysis and at least three times a week and each session almost for four hours having serum triglyceride or total cholesterol concentration \>200 mg/dl or serum HDL concentration \>40 mg/dl in the beginning of the study.

Exclusion Criteria

•taking carnitine supplement or the drug that interact with carnation lowering the seizure threshold in the last month being affected by liver function abnormalities, hypothyroidism, chronic infectious diseases (such as hepatitis), inflammatory diseases, CNS mass having the history of seizure.

Related studies

COMPLETEDPhase 3

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

NCT05425056 · Complication of Renal Dialysis, End Stage Renal Disease, and more

The Relationship Between the Flow of Arteriovenous Fistula and Cardiac Function in Haemodialysis Patients

NCT02747966 · Complication of Hemodialysis

COMPLETEDPhase 4

Intradialytic Parenteral Nutrition in Hemodialysis Patients

NCT00501956 · Malnutrition, Complication of Hemodialysis

Effects of Simple Sodium Alignment on Clinical Outcomes

NCT01825590 · Complication of Hemodialysis

COMPLETEDPhase 2

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

NCT00732069 · End Stage Renal Failure on Dialysis, Complication of Hemodialysis

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 19, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment54

Start dateAug 2009

Last updatedJan 19, 2011

Condition

Complication of Hemodialysis

Locations shown

Noor university hospital

Isfahan, Isfahan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 19, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions